Kari Varkila
MD, PhD, MBA, Advisor - Clinical & Regulatory Strategy
Kari Varkila has extensive experience in medical research and pharmaceutical development, including vaccines, and has held leadership positions in biopharmaceutical companies including Orion Pharma and GSK. Kari applies his translational expertise for advicing Tiltbio for clinical and regulatory strategy as well as corporate communications.
Tuija Keinonen
Pharm PhD, Professor of Practice, Chair of the Board of Directors, Advisor - Operational Exellence
